A physician says the board brought together endocrinologists, internists, gastroenterologists, cardiologists and gynecologists, each with a different view.
Recap by typeshit. Post by Facebook on Facebook.
A Facebook user criticizes telehealth marketing of tirzepatide and other GLP-1 services that targets new mothers, calling it predatory. One person's opinion.
Dr. Noc joined StarTalk to cover GLP-1 drugs, creatine, peptides and looksmaxxing. The full talk is out on YouTube and in podcast apps.
The obesity doctor says commenters once treated her early support for these medications as heresy. She adds that she saw their potential back in 2005.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Nausea hit 20% of users vs 6% on placebo, with other gut effects near placebo levels. A GP tells Medical News Today phase 3 data is still needed.
A general overview of what recent studies say about GLP-1 agonists. The link carries the full piece, with no specific findings shared up front.
Loading…